Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125(6):490–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632–4.

Article  CAS  PubMed  Google Scholar 

Falanga A, Russo L, Verzeroli C. Mechanisms of thrombosis in cancer. Thromb Res. 2013;131(Suppl):S59-62.

Article  CAS  PubMed  Google Scholar 

Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110(10):2339–46.

Article  PubMed  Google Scholar 

Kuderer NM, Francis CW, Culakova E, Khorana AA, Ortel T, Falanga A, et al. Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy. J Clin Oncol [Internet]. 2008;26(15\_suppl):9521. Available from: https://doi.org/10.1200/jco.2008.26.15_suppl.9521.

Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715–22.

Article  CAS  PubMed  Google Scholar 

Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712–23. https://doi.org/10.1182/blood-2013-04-460121.

Article  CAS  PubMed  Google Scholar 

White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, et al. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med. 2005;165(15):1782–7.

Article  PubMed  Google Scholar 

Mulder FI, Horváth-Puhó E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959–69.

Article  CAS  PubMed  Google Scholar 

Adelborg K, Corraini P, Darvalics B, Frederiksen H, Ording A, Horváth-Puhó E, et al. Risk of thromboembolic and bleeding outcomes following hematological cancers: a Danish population-based cohort study. J Thromb Haemost. 2019;17(8):1305–18.

Article  PubMed  Google Scholar 

Holstein SA, McCarthy PL. Immunomodulatory drugs in multiple myeloma: mechanisms of action and clinical experience. Drugs. 2017;77(5):505–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leebeek FWG. Update of thrombosis in multiple myeloma. Thromb Res. 2016;140(Suppl):S76-80.

Article  CAS  PubMed  Google Scholar 

De Stefano V, Larocca A, Carpenedo M, Cavo M, Di Raimondo F, Falanga A, et al. Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel. Haematologica. 2022;107(11):2536–47.

Colombo R, Gallipoli P, Castelli R. Thrombosis and hemostatic abnormalities in hematological malignancies. Clin Lymphoma, Myeloma Leuk [Internet]. 2014;14(6):441–50. Available from: https://doi.org/10.1016/j.clml.2014.05.003.

Sorigue M, Orna E, Sancho J-M. Venous thromboembolism in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with lenalidomide: a systematic review. Leuk Lymphoma. 2018;59(11):2602–11.

Article  CAS  PubMed  Google Scholar 

Reeves BN, Moliterno AR. Thrombosis in myeloproliferative neoplasms: update in pathophysiology. Curr Opin Hematol. 2021;28(5):285–91.

Article  CAS  PubMed  Google Scholar 

Sankar K, Stein BL, Rampal RK. Thrombosis in the Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Treat Res. 2019;179:159–78.

Article  CAS  PubMed  Google Scholar 

Falanga A, Rickles FR. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Best Pract Res Clin Haematol. 2003;16(3):463–82.

Article  CAS  PubMed  Google Scholar 

David S, Mathews V. Mechanisms and management of coagulopathy in acute promyelocytic leukemia. Thromb Res. 2018;164(Suppl):S82–8.

Article  CAS  PubMed  Google Scholar 

Paterno G, Palmieri R, Forte V, Del Prete V, Gurnari C, Guarnera L, et al. Predictors of early thrombotic events in adult patients with acute myeloid leukemia: a real-world experience. Cancers (Basel). 2022;14(22).

Del Principe MI, Del Principe D, Venditti A. Thrombosis in adult patients with acute leukemia. Curr Opin Oncol. 2017;29(6):448–54.

Article  PubMed  Google Scholar 

López JA, Kearon C, Lee AY. Deep venous thrombosis. Hematology Am Soc Hematol Educ Program. 2004:439–56. https://doi.org/10.1182/asheducation-2004.1.439.

Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2013;11(2):223–33.

Article  CAS  PubMed  Google Scholar 

Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies. J Clin Oncol [Internet]. 2009 Oct 10;27(29):4848–57. Available from: https://doi.org/10.1200/JCO.2009.22.8197.

Rickles FR, Falanga A, Montesinos P, Sanz MA, Brenner B, Barbui T. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like? Thromb Res. 2007;120(SUPPL. 2):99–106.

Article  Google Scholar 

Kekre N, Connors JM. Venous thromboembolism incidence in hematologic malignancies. Blood Rev. 2019;33:24–32.

Article  PubMed  Google Scholar 

Falanga A, Marchetti M, Vignoli A, Balducci D, Russo L, Guerini V, et al. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules. Exp Hematol. 2007;35(5):702–11.

Article  CAS  PubMed  Google Scholar 

Martella F, Cerrano M, Di Cuonzo D, Secreto C, Olivi M, Apolito V, et al. Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Ann Hematol. 2022;101(4):855–67.

Article  CAS  PubMed  Google Scholar 

Lee Y-G, Kim I, Kwon J, Yoon S, Park S, Song L, et al. Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia. Thromb Haemost [Internet]. 2015 Jan 27;113(01):201–8. Available from: https://doi.org/10.1160/TH13-12-1020.

Perek S, Khatib A, Izhaki N, Khalaila AS, Brenner B, Horowitz NA. A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis. Eur J Intern Med [Internet]. 2022;101(March):68–75. Available from: https://doi.org/10.1016/j.ejim.2022.04.025.

Kwaan HC. Complications of implanted nonbiologic devices: an overview. Semin Thromb Hemost. 2018;44(1):7–11.

Article  CAS  PubMed  Google Scholar 

Iba T, Levi M, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost. 2020;46(1):89–95.

Article  PubMed  Google Scholar 

Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64–77.

Article  CAS  PubMed  Google Scholar 

Falanga A, Panova-Noeva M, Russo L. Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol. 2009;22(1):49–60.

Article  CAS  PubMed  Google Scholar 

Dicke C, Amirkhosravi A, Spath B, Jiménez-Alcázar M, Fuchs T, Davila M, et al. Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study. Exp Hematol Oncol. 2015;4:22.

Article  PubMed  PubMed Central  Google Scholar 

Tzoran I, Rebibo-Sabbah A, Brenner B, Aharon A. Disease dynamics in patients with acute myeloid leukemia: new biomarkers. Exp Hematol. 2015;43(11):936–43.

Article  CAS  PubMed  Google Scholar 

Key NS, Chantrathammachart P, Moody PW, Chang J-Y. Membrane microparticles in VTE and cancer. Thromb Res. 2010;125(Suppl):S80–3.

Article  PubMed  Google Scholar 

Horowitz NA, Brenner B. Thrombosis in hematological malignancies: mechanisms and implications. Thromb Res [Internet]. 2020;191(October 2019):S58–62. Available from: https://doi.org/10.1016/S0049-3848(20)30398-4.

Vallier L, Cointe S, Lacroix R, Bonifay A, Judicone C, Dignat-George F, et al. Microparticles and fibrinolysis. Semin Thromb Hemost. 2017;43(2):129–34.

Article  CAS  PubMed  Google Scholar 

Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res. 2001;102(6):V215–24.

Article  CAS  PubMed  Google Scholar 

Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162(11):1245–8.

Article  PubMed  Google Scholar 

Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, et al. 2019 International Clinical Practice Guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2019;20(10):e566–81.

Article  PubMed  Google Scholar 

Grilz E, Posch F, Nopp S, Königsbrügge O, Lang IM, Klimek P, et al. Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis. Eur Heart J. 2021;42(23):2299–307.

Cronin-Fenton DP, Søndergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006. Br J Cancer. 2010;103(7):947–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer: a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404–13.

Article  PubMed